Genertec Universal Medical Group Co. Ltd. reported a stable and improving operation for the first quarter of 2025. During this period, the Group's sales increased by approximately 16.1% compared to the same period in 2024. The profit for the period also saw an increase of about 14.3% compared to the previous year, with the profit attributable to owners of the parent rising by approximately 16.7%. In the integrated healthcare business segment, the Group made significant efforts to enhance the quality and efficiency of healthcare services. This was achieved through standardized disease management, optimizing medical resource utilization, and ensuring effective treatment and service quality. The member medical institutions under the Group noted an increase in outpatient and emergency visits, demonstrating strong performance in the first quarter of 2025.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。